X0305 4 2011-09-27 0 0001451980 BIOCANCELL THERAPEUTICS INC. BICL.TA 0001524520 Ben-Am Monique 8 HARTOM ST JERUSALEM L3 97775 ISRAEL 0 1 0 0 VP Clinical Development Employee Options 2011-09-27 4 A 0 200000 0 A 2022-09-27 Common Stock 200000 200000 D The exercise price is 1.86 NIS per share. 37,500 options shall vest and be exercisable one year after the grant, and an additional 9,375 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2012 until 150,000 options are vested or until vesting is terminated in accordance with the terms of the options. An additional 50,000 options shall vest and be exercisable upon achievement of a pre-determined milestone. Monique Ben-Am 2012-03-28